Autore
Acconci, Pia

Titolo
La riduzione del prezzo dei farmaci essenziali: uno strumento necessario ma non sufficiente per la tutela della salute nel quadro del diritto internazionale
Periodico
Diritti umani e diritto internazionale
Anno: 2013 - Volume: 7 - Fascicolo: 2 - Pagina iniziale: 437 - Pagina finale: 452

With the judgment Novartis AG v. Union of India & Others of 1 April 2013, the Supreme Court ofIndia has denied that frivolous innovations of a patented medicine can be patented as a new drugunder the Indian Patents Act. The Court reached this conclusion since this Act aims to promoteuniversal access to essential drugs by facilitating the production and exportation of cheap genericdrugs. The article focuses on the relationship between the access to essential drugs and the guaranteeof the right to health under international law. For the purpose of the protection of such a right,the reduction of the price of essential drugs is important, but not sufficient, as emphasized by theUN Committee of the Economic, Social and Cultural Covenant, in particular within its GeneralComment on the right to health, and by the Special Rapporteur on the right to health of the UNCouncil of Human Rights within several reports. To this end, States and other actors of internationalrelations, such as multinational enterprises, should promote the satisfaction of the socialneeds of developing countries as a whole.



SICI: 1971-7105(2013)7:2<437:LRDPDF>2.0.ZU;2-F
Testo completo: http://www.mulino.it/download/article/10.12829/74162
Testo completo alternativo: http://www.mulino.it/doi/10.12829/74162

Esportazione dati in Refworks (solo per utenti abilitati)

Biblioteche ACNP che possiedono il periodico